Please assess the completion status of the following clinical trial:

Trial Title: Dilapan-S® for Induction of Labor The Feasibility Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Planned induction of labor ≥ 39 weeks~2. Singleton gestation~3. Vertex presentation~4. Cervical dilation \<3cm~Exclusion Criteria:~1. Placenta previa~2. Placenta accreta~3. Vasa previa~4. Preterm prelabor rupture of membranes~5. Non-english speaking~6. \<18 years old~7. Multiple gestation~8. Prior cesarean delivery~9. Prior myomectomy~10. Fetal malpresentation~11. Active vaginal bleeding~12. Cervical dilation \>1 cm~13. Uterine anomaly (didelphysis, bicornuate)~14. Intrauterine growth restriction \<10th%~15. Fetal anomalies~16. Requirements to be inpatient~17. Polyhydramnios (AFI\>25cm or MVP\>8cm)~18. Chronic hypertension on medications~19. Gestational hypertension/preeclampsia~20. GDMA2, DM1, DM2~21. Hepatitis B or C~22. HIV

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Dilapan S (Type: OTHER): Placement of dilators

Based on this trial design, predict the completion outcome and termination type (if applicable).